Product Description

Movfor is a brand of Molnupiravir 200 mg, an oral antiviral medication developed for the treatment of mild to moderate COVID-19 in adults who are at high risk of disease progression. It works by introducing errors in the viral RNA, preventing the virus from multiplying in the body.

Movfor should be taken under the supervision of a healthcare provider and initiated within 5 days of symptom onset.

Key Benefits

• Reduces the risk of hospitalization and severe complications
• Convenient oral capsule form
• Effective against multiple variants of COVID-19
• Short 5-day treatment duration

Product Details

• Generic Name: Molnupiravir
• Strength: 200 mg
• Form: Capsules
• Route of Administration: Oral
• Packaging: Typically 40 capsules for a 5-day course
• Storage: Store below 30°C, in a cool, dry place

Dosage & Usage Instructions

• Take 800 mg (4 capsules) every 12 hours
• Continue for 5 days (total of 40 capsules)
• Start within 5 days of symptom onset
• Take with or without food
• Complete the full course even if you feel better

Precautions & Warnings

• Not recommended during pregnancy or breastfeeding
• Use effective contraception during and after treatment
• Not approved for patients under 18 years
• Consult a doctor if you have existing kidney or liver issues

FAQs

1. What is Movfor used for?

Movfor is used to treat mild to moderate COVID-19 in adults at risk of developing severe illness.

2. How soon should I start treatment?

Treatment must begin within 5 days of symptoms appearing for best results.

3. Can pregnant women take Movfor?

No. It is not recommended for use during pregnancy or breastfeeding.

4. Are there side effects?

Common side effects may include headache, nausea, and diarrhea. Most are mild and manageable.